Recently, it was reported that immune complex-loaded dendritic cells were superior to soluble immune complexes as an anti-tumor vaccine in animals [27], Furthermore, antigen-antibody immune complexes were reported to empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo[28]. Here, CD8A is linked to neoplasm.